Advanced Hepatology Updates in MASH, Viral Hepatitis, Autoimmune Liver Disease & Liver Transplantation

Chronic liver disease is evolving rapidly as new metabolic syndromes, antiviral therapies, fibrosis-directed treatments, and transplant strategies reshape modern hepatology practice. The Scripps 40th Annual New Treatments in Chronic Liver Disease 2026 program provides a clinically focused review of the latest developments in liver disease diagnosis, therapeutics, and transplant medicine, with particular emphasis on emerging metabolic liver disorders, functional viral hepatitis cures, autoimmune hepatology, and complications of advanced cirrhosis.

This annual Scripps conference explores the changing landscape of hepatology through expert-led discussions, panel reviews, and evidence-based clinical updates designed for physicians managing increasingly complex liver disease populations.

The educational package includes:

• 13 Video Lectures
• 13 Subtitle Files (.vtt)
• 12 PDF Files
• Total Size: 3.48 GB
• Course Year: 2026

The course reflects how hepatology is shifting from largely supportive management toward precision medicine, targeted biologics, metabolic intervention, and disease-modifying therapies.

The Rapid Transformation of Modern Hepatology

Over the past decade, hepatology has undergone major transformation due to advances in:

• Antiviral therapies
• Fibrosis assessment
• Metabolic liver disease classification
• Immunologic treatments
• Transplant optimization
• Noninvasive diagnostics
• Hepatocellular carcinoma therapies

At the same time, clinicians increasingly face rising prevalence of:

• Obesity-associated liver disease
• Alcohol-related liver disease
• Combined metabolic and alcohol-associated liver injury
• End-stage liver complications

The course repeatedly emphasizes that liver disease management now requires broader multidisciplinary integration involving:

• Endocrinology
• Obesity medicine
• Addiction medicine
• Oncology
• Transplant medicine
• Interventional radiology

MetALD: An Emerging Clinical Entity

One of the most clinically important topics covered is MetALD (Metabolic dysfunction-associated Alcohol-related Liver Disease).

This emerging classification reflects the growing recognition that many patients demonstrate overlapping:

• Metabolic dysfunction
• Obesity-related liver injury
• Alcohol-associated hepatic damage

rather than fitting into purely isolated diagnostic categories.

The lectures examine:

• Diagnostic criteria
• Risk stratification
• Disease progression
• Metabolic risk factors
• Management strategies

In practice, distinguishing metabolic and alcohol-related contributions to liver disease can be challenging because both pathways frequently coexist and synergistically worsen fibrosis progression.

MASH Cirrhosis & Disease Reversibility

The MASH (Metabolic dysfunction-associated Steatohepatitis) sessions review:

• Fibrosis progression
• Cirrhosis reversibility
• Emerging anti-fibrotic therapies
• Weight reduction strategies
• Metabolic interventions

One of the more important evolving concepts in hepatology is the possibility that even advanced fibrosis and compensated cirrhosis may demonstrate partial reversibility under certain treatment conditions.

The course explores:

• Histologic improvement data
• Clinical trial evidence
• Pharmacologic therapies
• Lifestyle interventions
• Bariatric and obesity medicine considerations

Obesity Treatment & Liver Disease

The obesity medicine discussions appropriately recognize obesity as a central driver of modern hepatology practice.

Topics include:

• Weight reduction therapies
• GLP-1 receptor agonists
• Metabolic syndrome management
• Hepatic steatosis reduction
• Cardiometabolic risk improvement

As obesity-related liver disease becomes increasingly prevalent worldwide, clinicians must integrate:

• Nutrition management
• Endocrine therapy
• Cardiovascular risk reduction
• Behavioral medicine

into liver disease treatment planning.

Viral Hepatitis & Functional Cure Strategies

The viral hepatitis sessions provide updates on:

• Hepatitis B functional cures
• Hepatitis C management
• Delta hepatitis treatment advances
• Antiviral therapy optimization

The concept of “functional cure” in hepatitis B represents one of the most important evolving areas in hepatology.

The course reviews:

• Novel antiviral strategies
• Immune-targeted therapies
• Viral suppression goals
• Long-term monitoring considerations

The delta hepatitis discussions are particularly relevant because HDV remains one of the most aggressive viral liver diseases, historically associated with limited treatment options.

Autoimmune Liver Disease Updates

The autoimmune hepatology sections examine:

• Autoimmune hepatitis
• Primary biliary cholangitis (PBC)
• Primary sclerosing cholangitis (PSC)
• Novel biomarkers
• Emerging therapies

Autoimmune liver diseases remain diagnostically and therapeutically complex because disease activity, fibrosis progression, and treatment response can vary substantially among patients.

The course highlights evolving therapeutic approaches and updated understanding of disease mechanisms.

Drug-Induced Liver Injury (DILI)

The DILI discussions focus on:

• Diagnostic evaluation
• Pattern recognition
• Medication-related hepatotoxicity
• Differential diagnosis challenges

Drug-induced liver injury remains one of the most difficult areas in hepatology because presentations often mimic:

• Viral hepatitis
• Autoimmune disease
• Cholestatic disorders
• Acute liver failure syndromes

The lectures emphasize careful clinical reasoning and exclusion-based diagnosis.

Hepatocellular Carcinoma (HCC)

The HCC sections review:

• Liver mass evaluation
• Screening strategies
• Emerging systemic therapies
• Multidisciplinary management
• Transplant considerations

Hepatocellular carcinoma management has changed dramatically with the introduction of:

• Immunotherapy combinations
• Targeted therapies
• Locoregional treatment advances

The course explores how evolving oncology therapies are reshaping prognosis and treatment sequencing in advanced liver cancer.

Ascites & Hepatorenal Syndrome

Management of advanced cirrhosis complications remains a major focus.

Topics include:

• Ascites management
• Hepatorenal syndrome
• Volume management
• Albumin use
• Renal support strategies

Clinical decision-making becomes particularly difficult in decompensated cirrhosis where:

• Portal hypertension
• Renal dysfunction
• Infection risk
• Hemodynamic instability

often coexist simultaneously.

Liver Transplant Selection & Advanced Hepatology Care

The transplant board sessions review:

• Candidate selection
• MELD prioritization
• Contraindications
• Comorbidity assessment
• Long-term transplant outcomes

As liver disease therapies continue improving, transplant evaluation increasingly involves balancing:

• Disease reversibility potential
• Frailty assessment
• Malignancy risk
• Cardiometabolic disease burden

The course appropriately emphasizes multidisciplinary transplant decision-making.

Real-World Clinical Relevance

A major strength of the conference is its focus on clinically actionable hepatology.

The sessions repeatedly address:

• Translating clinical trial data into practice
• Evidence-based therapeutic selection
• Longitudinal liver disease management
• Complication prevention
• Personalized patient care
• Emerging treatment pathways

The program reflects the reality that hepatology increasingly intersects with:

• Metabolic medicine
• Oncology
• Transplantation
• Immunology
• Preventive medicine

What’s Included

• 13 expert hepatology video lectures
• 13 subtitle files (.vtt)
• 12 downloadable PDFs
• Total size: 3.48 GB
• MASH and MetALD updates
• Viral hepatitis and delta hepatitis discussions
• Autoimmune liver disease reviews
• Liver transplant and HCC management sessions

Final Expert Perspective

Modern hepatology is undergoing a major shift as advances in antiviral therapy, metabolic medicine, immunology, fibrosis reversal research, and liver transplantation continue reshaping patient care. Clinicians increasingly manage highly complex patients with overlapping metabolic, inflammatory, infectious, and oncologic liver disease processes.

The Scripps 40th Annual New Treatments in Chronic Liver Disease 2026 program provides a clinically grounded and up-to-date review of these developments through expert-led discussions focused on practical management, emerging therapeutics, and evolving disease classification. For hepatologists, gastroenterologists, and transplant specialists seeking advanced updates in chronic liver disease management, this course offers a highly relevant and evidence-driven educational resource.

 Topics

1. 01 The Emerging Clinical Entity of MetALD Diagnosis, Risk, and Management

2. 02 Treatment of MASH Cirrhosis Is it Reversible

3. 03 Obesity Treatment The Essentials

4. 04 Pediatric MASH Approaches to Diagnosis and Treatment VIDEO PDF NOT RELEASE

5. 05 Panel Discussion Q&A

6. 06 Updates on Diagnosis and Treatment of Autoimmune Hepatitis

7. 07 Drug Induced Liver Injury

8. 08 Hepatitis B Functional Cures

9. 09 Using Medication Assisted Therapy in Hepatitis C

10. 10 Delta Hepatitis

11. 11 Panel Discussion Q&A

12. 12 HCC VIDEO PDF NOT RELEASE

13. 13 Transplant Selection Board

14. 14 WILLIAM S. HAUBRICH LECTURE Updates in PBC and PSC

15. 15 Panel Discussion Q&A

 Topics

1. Abnormal Labs in that Inbox.mp4

2. Abnormal Thyroid Function Tests What to Do.mp4

3. Acute Psychosis and Chronic Mental Health on the Wards.mp4

4. Acute Thrombosis Common Challenges in the Hospital.mp4

5. Addiction Medicine Essentials for the Inpatient Clinician.mp4

6. Addressing the Changing Dynamics of State-Based Medical Licensure for IMGs.mp4

7. Adolescents and Young Adults With Common Mental Health Disorders.mp4

8. AFib- Common Challenges in the Hospital.mp4

9. Aging Out of Pediatric Care When Living With Pediatric and Congenital Conditions.mp4

10. AI in Internal Medicine to Improve Global Outcomes – An ACP and EFIM Joint Session.mp4

11. Annals of Internal Medicine Recent Articles That You Should Know About.mp4

12. Antiphospholipid Syndrome Too Complicated to Diagnose.mp4

13. Antiplatelet Agents in the Patient With Coronary Artery Disease.mp4

14. Aortic Stenosis Evaluation and Management.mp4

15. Approach to Patients Who Are Transgender and Gender-Diverse in Primary Care.mp4

16. Approach to Soft Tissue Masses.mp4

17. Approach to the Patient With Chronic Sinusitis.mp4

18. Artificial Intelligence Ethics and Bias.mp4

19. Artificial Intelligence in Hospital Medicine.mp4

20. Artificial Intelligence Use in the Practice Setting.mp4

21. Assessment and Management of Frail Older Patients in the Hospital A Case-Based Approach.mp4

22. Asthma 2026 State of the Art.mp4

23. Autonomics for Internal Medicine Physicians.mp4

24. Bacteremia Clinical Guidance What’s New.mp4

25. Beyond the Checkbox Understanding Physician Performance Measurement.mp4

26. C. Wesley Eisele Lecture Medicare Transition to Value-Based Care—How It Affects My Practice.mp4

27. Cannabis Use Considerations for Caring for the Hospitalized Patient.mp4

28. Cardiorenal Syndrome The Path to Decongestion.mp4

29. Case-Based Management of Obesity.mp4

30. Challenges in Geriatric Medication Management An Interactive, Case-Based Presentation.mp4

31. Challenges in Prescribing in 2026 Drug Shortages, Prior Authorization, Drug Side Effects & Recalls.mp4

32. Chest Pain Common Challenges in the Hospital.mp4

33. Chronic Lymphocytic Leukemia A Primer and What’s New.mp4

34. Chronic Pain at a Crossroads Opioid Risks, Cannabis Guidance, and Controversies.mp4

35. Chronic Pancreatitis Challenges in Diagnosis and Management.mp4

36. Chronic Wound Management for Internal Medicine Physicians.mp4

37. Cirrhosis and Chronic Liver Disease.mp4

38. Clinical Pearls Addiction Medicine and Endocrinology.mp4

39. Clinical Pearls Gastroenterology and General Internal Medicine.mp4

40. Clinical Pearls Neurology and Infectious Diseases.mp4

41. Clinical Triad Inpatient Device Management.mp4

42. Cognitive Impairment Evaluation and Management for the Internal Medicine Physician.mp4

43. Colorectal Cancer Screening.mp4

44. Consult Talk.mp4

45. Contemporary Lipid Management in a New Era of Options.mp4

46. Contemporary Management of Atrial Fibrillation.mp4

47. Continuous Glucose Monitoring in Patients With Diabetes Mellitus.mp4

48. COVID-19, Influenza, and Respiratory Syncytial Virus What’s New.mp4

49. Current State of U.S. Vector-Borne Infections.mp4

50. Data We Didn’t Ask For Navigating Direct-to-Consumer Medical Testing.mp4

51. Delirium During Hospitalization.mp4

52. Diagnosis of Screen-Detectable Cancer in Adults Under the Age of 50.mp4

53. Direct Contracting and Concierge Medicine.mp4

54. Disability-Related Biases Holding Ourselves Accountable.mp4

55. Dr. Ananda Prasad Lecture in Physiology GLP and Other Gut Hormones-Pathophysiologic Insights.mp4

56. Early Career Transitions.mp4

57. Electrolyte Abnormalities in the Hospital Clinical Pearls.mp4

58. Endocrine Challenges in the Hospital Setting.mp4

59. Evaluation of the Outpatient With Chest Pain.mp4

60. Female Sexual Dysfunction Evaluation and Treatment.mp4

61. Fibromyalgia Current Understanding and Evidence-Based Treatment.mp4

62. Fluids With Early Use of Vasopressors for Septic Shock Is It Safe.mp4

63. Food Allergy Current Concepts.mp4

64. Gastroenterology for the Inpatient Clinician.mp4

65. Global Care Gap Physician Shortages in Rural and Underserved Areas – An ACP and ISIM Joint Session.mp4

66. Global Health Volunteerism at Home and Abroad.mp4

67. Hair Loss in Women Causes and Treatments.mp4

68. Heart Failure Common Challenges in the Hospital.mp4

69. Heart Failure With Recovered Ejection Fraction A Clinical Approach.mp4

70. Help, My Food Got Stuck.mp4

71. HIV and Sexually Transmitted Infections Screening and Pre- and Post-exposure Prophylaxis.mp4

72. Hospital at Home and Creative Models to Reduce Length of Stay and Readmissions.mp4

73. Hot Issues in Health Policy.mp4

74. ‘Hot Topics’ in Ethics.mp4

75. Hot Topics in Health IT.mp4

76. Hypertension How Low Should We Go and How Do We Get There.mp4

77. Hypoglycemia in Patients Without Diabetes Mellitus How to Evaluate.mp4

78. IMM 2026 Highlights and Doctor’s Dilemma The Finals (Session not eligible for CME credit).mp4

79. Immune Checkpoint Inhibitors Things to Know in the Inpatient Setting.mp4

80. Innovations in Obstructive Sleep Apnea.mp4

81. Inpatient Bleeding and Anemia Management.mp4

82. Inpatient Management of Diabetes for the Hospitalist.mp4

83. Inpatient Perioperative Medicine High-Yield Pearls for Hospitalists.mp4

84. Interpreting the Abnormal ANA Why Did I Order It.mp4

85. Interstitial Lung Disease Implementing Guidelines for Patient-Centered Care.mp4

86. Iron Deficiency Anemia Don’t Get Rusty.mp4

87. Irritable Bowel Syndrome Explained Disorders of Gut–Brain Interaction.mp4

88. It’s Not AFib Management of Other Common Arrhythmias.mp4

89. Managing Behavioral Symptoms in Dementia.mp4

90. Managing Hypertension in Special Populations.mp4

91. Managing Uncertainty in Clinical Reasoning.mp4

92. Martin A. Samuels Memorial Lecture Migraine Headaches.mp4

93. MASLD and MASH in Primary Care.mp4

94. Medical Implications of Substance Use Disorder Best Practices for the Patient & the Disease Process.mp4

95. Multiple Myeloma What’s New.mp4

96. Multiple Small Feedings of the Mind Cardiology, Women’s Health, and Sports Medicine.mp4

97. Multiple Small Feedings of the Mind Endocrinology, Sleep Medicine, and Pulmonology Critical Care.mp4

98. Multiple Small Feedings of the Mind- Pain Management, Medical Oncology, & Gastroenterology Nutrition.mp4

99. Nephrology in the Inpatient Setting A Case-Based Approach.mp4

100. Neuromuscular Disease Pearls for the Inpatient Clinician.mp4

101. New in Annals of Internal Medicine Hear it First from the Authors.mp4

102. New Meds in Primary Care.mp4

103. News You Can Use Current Clinical Guidelines in Breast and Colorectal Cancer Screening.mp4

104. Nutrition Assessment and Interventions for the Internal Medicine Physician.mp4

105. Obstructive and Restrictive Lung Disease Challenges in the Inpatient Setting.mp4

106. Ocular Diseases for Internal Medicine Physicians.mp4

107. Oncologic Emergencies for Inpatient Clinicians.mp4

108. Opening Ceremony and Keynote Speaker.mp4

109. Palliative Care.mp4

110. Perimenopause An Approach to Evaluation and Management.mp4

111. Pneumonia and Other Respiratory Infections in the Hospital.mp4

112. Practice Gaps in Cirrhosis Care.mp4

113. Precision Oncology Breast Cancer as an Exemplar.mp4

114. Presentation Skills for Physicians Making Your Next Teaching Presentation Go Better Than Your Last.mp4

115. Primary Care of the Patient Who Has Received a Solid Organ Transplant.mp4

116. Procedural Bleeding Risk Assessment and Management DOACs and Liver Disease.mp4

117. Promoting Recovery From Critical Illness.mp4

118. Radiation Oncology for the Internal Medicine Physician.mp4

119. Radiologic Correlation Required High-Value Care Approach to the Incidental Abdominal Mass.mp4

120. Sarcopenic Obesity in Older Adults Does Weight Loss Mean Muscle Loss.mp4

121. Shock Recognition and Triage.mp4

122. Sports Medicine for the Primary Care Physician.mp4

123. Stroke Common Challenges in the Hospital.mp4

124. Syncope An Evidence-Based Approach to Inpatient Evaluations.mp4

125. Systemic Lupus Erythematosus.mp4

126. Systemic Vasculitis What the Internal Medicine Physician Should Know.mp4

127. Team-Based Approaches to Increase Vaccine Uptake.mp4

128. The Approach to the Patient Who Disagrees With Your Care.mp4

129. The Five Books That Changed Medicine.mp4

130. The Role and Risks of Psychedelics in the Management of Resistant Mental Health Disorders.mp4

131. Thieves’ Market.mp4

132. Thyroid Nodules Initial Evaluation and Monitoring of One or More Nodules.mp4

133. Top 10 Tips for Physician Contract Negotiation.mp4

134. Ultrasound Controversy Is the Physical Exam Obsolete.mp4

135. Update in Ambulatory General Internal Medicine.mp4

136. Update in Cardiology.mp4

137. Update in Critical Care Medicine.mp4

138. Update in Endocrinology.mp4

139. Update in Gastroenterology.mp4

140. Update in Geriatric Medicine.mp4

141. Update in Hematology.mp4

142. Update in Hospital Medicine.mp4

143. Update in Infectious Diseases.mp4

144. Update in Nephrology.mp4

145. Update in Oncology.mp4

146. Update in Pulmonary Medicine.mp4

147. Update in Rheumatology.mp4

148. Update in Women’s Health.mp4

149. Urinary Tract Infections From Asymptomatic Bacteriuria to Bacteremia.mp4

150. Urology for Primary Care.mp4

151. Vaginal Dryness During Menopause Diagnosis and Treatment.mp4

152. VITT and HIT What Just Happened and What Did We Learn From It.mp4

153. Volume Assessment and Fluid Management in the Hospital.mp4

154. Writing and Publishing Case Reports.mp4

Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder – 2026

Advanced Multidisciplinary Management of Alcohol Use Disorder in Liver Transplantation

📦 Product Details

Format: 11+ Videos (.mp4)
PDFs: None Included
Course Date: March 20, 2026
Access: On-demand
Focus: Liver Transplantation & Alcohol Use Disorder (AUD)
Target Audience: Hepatologists, transplant specialists, addiction medicine professionals, and multidisciplinary transplant teams

🩺 Program Overview

Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder 2026 is a comprehensive educational program exploring the rapidly evolving management of patients with alcohol use disorder (AUD) who require liver transplantation.

This multidisciplinary course provides clinicians with evidence-based insights into the medical, psychosocial, ethical, and behavioral complexities surrounding alcohol-associated liver disease (ALD), transplantation candidacy, relapse prevention, and long-term post-transplant care.

Designed for physicians, surgeons, addiction specialists, mental health professionals, nurses, social workers, and allied healthcare providers, the program highlights modern treatment strategies, collaborative care models, emotional intelligence in transplant leadership, and emerging therapies including GLP-1 receptor agonists.

Participants will gain practical knowledge on patient selection, psychosocial assessment, addiction treatment integration, ethical decision-making, relapse risk management, and multidisciplinary transplant care aimed at improving patient survival and long-term outcomes.

🎯 Key Features

• Advanced liver transplantation and addiction medicine education
• Focus on alcohol-associated liver disease (ALD)
• Multidisciplinary transplant management strategies
• Evidence-based AUD treatment approaches
• Ethical and psychosocial transplant decision-making
• Relapse prevention and long-term support planning
• Emerging therapies including GLP-1 receptor agonists
• Real-world case discussions and expert panel sessions

📚 What You Will Learn

• Understand the pathophysiology of alcohol-related liver disease
• Evaluate candidates with AUD for liver transplantation
• Apply evidence-based relapse prevention strategies
• Integrate psychosocial and ethical considerations into transplant care
• Analyze the role of the intestinal microbiome in addiction
• Recognize risk factors for post-transplant alcohol relapse
• Implement multidisciplinary addiction treatment approaches
• Explore emerging therapies including GLP-1 agonists
• Improve inpatient and outpatient management of AUD patients
• Optimize long-term transplant outcomes and survival

🫀 Core Topics Covered

🍷 Alcohol Use Disorder & Liver Disease

• Alcohol-associated liver disease (ALD)
• Alcohol-associated hepatitis and transplantation
• Effects of alcohol on MASLD
• Alcohol and liver cancer
• Medical management of AUD in ALD
• Advanced liver disease progression

🩺 Liver Transplantation & Candidate Evaluation

• Liver transplantation candidacy in AUD
• Absolute contraindications for liver transplant in ALD
• The 6-month abstinence rule controversy
• Medical and psychosocial transplant evaluation
• Ethical challenges in transplant decision-making
• Transplant medical review board management

🧠 Addiction Medicine & Behavioral Health

• Managing individuals with AUD and addiction
• Outpatient community-based addiction treatment
• Emotional intelligence in transplant program leadership
• Behavioral relapse risk factors
• Integrated addiction treatment models
• Psychosocial support strategies

🧬 Gut-Liver Axis & Emerging Science

• Intestinal microbiome and addiction pathways
• Gut-liver axis interactions
• Dysbiosis and alcohol addiction
• GLP-1 receptor agonists and addiction treatment
• Metabolic dysfunction-associated steatotic liver disease (MASLD)
• Emerging biologic and pharmacologic therapies

🏥 Post-Transplant Management & Relapse Prevention

• Strategies to reduce alcohol relapse after transplantation
• Inpatient management of AUD post-transplant
• Long-term monitoring and support
• Multidisciplinary transplant follow-up
• Case-based management discussions
• Survival and outcome optimization

⚖️ Ethical & Multidisciplinary Challenges

• Ethical considerations in transplant eligibility
• Evaluation of critically ill transplant candidates
• Managing intubated transplant patients
• Team-based transplant decision-making
• Panel discussions on complex transplant cases
• Collaborative transplant care models

🎥 Featured Sessions

• Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder
• Emotional Intelligence and Managing a Transplant Program
• Managing Individuals with AUD and Addiction
• Alcohol-Associated Hepatitis and Liver Transplantation
• Effects of Alcohol on MASLD
• Intestinal Microbiome and Addiction
• Strategies to Reduce Alcohol Relapse After Liver Transplantation
• Medical Management of AUD in ALD
• GLP-1 Receptor Agonists and Addiction
• AUD and Kidney Transplantation
• Panel Discussion: Ethical and Clinical Challenges of Liver Transplantation

👨‍⚕️ Target Audience

• Hepatologists
• Gastroenterologists
• Transplant surgeons
• Addiction medicine specialists
• Psychiatrists and psychologists
• Internal medicine physicians
• Primary care physicians
• Social workers
• Nurses and transplant coordinators
• Allied health professionals involved in transplant care

🚀 Why This Course Stands Out

• Combines hepatology, transplantation, and addiction medicine in one program
• Strong focus on multidisciplinary patient-centered care
• Addresses real-world ethical and psychosocial challenges
• Includes emerging therapies and modern addiction science
• Practical guidance for relapse prevention and long-term management
• Features expert-led case discussions and panel sessions
• Covers both inpatient and outpatient transplant care strategies
• Ideal for clinicians managing complex alcohol-associated liver disease and transplantation cases

Houston Methodist 11th Annual Exploring Frontiers in the Management of Digestive and Liver Disorders 2026

+ Include: Videos (.mp4)  Only NO PDFS

Videos Only no PDFs

The Course provides a platform to update the Rocky Mountain community of practicing gastroenterologists, hepatologists, primary care providers, and nursing professionals with the latest updates in Gastroenterology and Hepatology. We are excited to present highly focused and important sessions including Luminal Gastroenterology, Hepatology, Therapeautic Endoscopy, and updated in Colorectal Cancer Preventio

list